Search results
Results from the WOW.Com Content Network
In a study of more than 50,000 patients in the Mayo Clinic Health System https://bit.ly/37Btmhf, researchers found the effectiveness of Moderna's vaccine against infection had dropped to 76% in ...
Thursday, Moderna Inc (NASDAQ:MRNA) unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, enabling a focus on ten prioritized products. The company ...
Moderna’s total revenue for Q3 2023 was $1.8 billion, compared to $3.4 billion in the same period in 2022, the company reported on Thursday. This is mainly due to a decrease in sales of the ...
The Moderna news followed preliminary results from the Pfizer-BioNTech vaccine candidate, BNT162b2, with Moderna demonstrating similar efficacy, but requiring storage at the temperature of a standard medical refrigerator of 2–8 °C (36–46 °F) for up to thirty days or −20 °C (−4 °F) for up to four months, whereas the Pfizer-BioNTech ...
Moderna was founded in 2010 by Derrick Rossi, Timothy A. Springer, Kenneth R. Chien, Robert S. Langer, and Noubar Afeyan. [9] Stéphane Bancel, the current CEO, was appointed as CEO in 2011.
Pfizer and Moderna may soon begin emergency distribution of coronavirus vaccines created with genetic technology. Here's everything you need to know:How do these vaccines work? Up to now, vaccines ...
On 18 December 2020, the US FDA granted an EUA for mRNA-1273, the Moderna vaccine. [26] [27] [28] Vaccine manufacturers are awaiting full approvals to name their vaccines. [117] [118] Moderna submitted a request for an EUA for mRNA-1273 to the FDA on 30 November 2020. [119] [120] On 18 December 2020, the FDA granted an EUA for the Moderna ...
Moderna’s management expressed stronger confidence in their pre-election strategy to focus on investments in oncology and rare diseases while reducing reliance on respiratory infectious diseases.